(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COGENTIDE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COGENTIDE

ST13

US500000098461517

Class

42

Filing

98461517

Registration

7685409

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

02/11/2025

Trademark type

Word

Nice classes

42

Filing date

03/21/2024

Registration date

02/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/11/2025

Last transaction

02/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

New Taipei City, TW

Examiner

BARREDA, AMBER

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

TAIWAN COGENTIDE NOVEL DRUG CORP.

Representatives

Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Professional consulting services and advice about agricultural chemistry; Scientific research consulting in the field of agricultural fertilization and irrigation; Research in the field of chemistry; Chemical analysis; Research laboratory analysis services in the field of chemistry; Cosmetic research; Biological research; Bacteriological research; Clinical lab test of medical reagentproviding reagent sample testing services for others for scientific purposes; Medical and scientific research in the field of medical reagents; Providing research and development services of pharmaceutical drugs; Technological research in the field of pharmaceutical drugs; Conducting technical research in the field of pharmaceutical drugs; Industrial research in the field of pharmaceutical drugs; Testing of pharmaceuticals; Quality control for others; Material testing; Inspection of food for quality control purposes; Product quality testing

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/24/2024

PUBO

PUBLISHED FOR OPPOSITION

12/24/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/18/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

11/28/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/22/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/22/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/22/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/04/2024

GNSL

LETTER OF SUSPENSION E-MAILED

10/04/2024

CNSL

SUSPENSION LETTER WRITTEN

10/04/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

10/04/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/04/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

10/04/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/04/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/03/2024

GNRT

NON-FINAL ACTION E-MAILED

10/03/2024

CNRT

NON-FINAL ACTION WRITTEN

10/03/2024

DOCK

ASSIGNED TO EXAMINER

09/30/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/17/2024

NWAP

NEW APPLICATION ENTERED

03/21/2024

Continuous trademark protection

Get notified about every new filing that threatens COGENTIDE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.